Causal relationship between key genes and metabolic dysfunction‐associated fatty liver disease risk mediated by immune cells: A Mendelian randomization and mediation analysis

Documenti analoghi

• Associations between cuprotosis‐related genes and the spectrum of metabolic dysfunction‐associated fatty liver disease: An exploratory study
  di: Hai‐Yang Yuan, et al.
  Pubblicazione: (2024)
• Serum bile acid profiles are associated with heart failure with preserved ejection fraction in patients with metabolic dysfunction‐associated fatty liver disease: An exploratory study
  di: Xiao‐Dong Zhou, et al.
  Pubblicazione: (2024)
• Hepatic thyroid hormone receptor‐β signalling: Mechanisms and recent advancements in the treatment of metabolic dysfunction‐associated steatohepatitis
  di: Stergios A. Polyzos, et al.
  Pubblicazione: (2024)
• Metabolic dysfunction‐associated steatotic liver disease and sex‐specific risk of fatal and non‐fatal cardiovascular events: A meta‐analysis
  di: Mohamad Jamalinia, et al.
  Pubblicazione: (2025)
• Is the combination of resmetirom and semaglutide useful for the treatment of metabolic dysfunction‐associated steatohepatitis?
  di: Stergios A. Polyzos, et al.
  Pubblicazione: (2026)